U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Measuring Dystrophin in Dystrophinopathy Patients and Interpreting the Data
  1. News & Events for Human Drugs

Measuring Dystrophin in Dystrophinopathy Patients and Interpreting the Data

Inclement weather is expected in Washington DC and surrounding suburbs beginning early morning on March 20. If the government announces a delayed opening (2 hours for example), the meeting time will also be delayed by that amount of time. For the latest information on government closing and delays, please check the opm.gov website.

The Food and Drug Administration (FDA) is holding a public scientific workshop on March 20, 2015, to discuss dystrophin protein quantification methodologies for human tissue. This workshop is being cosponsored by the National Institutes of Health (NIH). The purpose of the workshop is to discuss currently available methodologies and to identify scientific knowledge gaps and opportunities for improving dystrophin protein detection in the context of drug development.


March 20, 2015


8:30 a.m. to 5:30 p.m.


FDA White Oak Campus
10903 New Hampshire Avenue
Bldg. 31, Room 1503A
Silver Spring, MD 20993


Registration must be received by March 17, 2015. The closing date for written and electronic comments to the division of dockets management is May 20, 2015.


For more information: please contact Mary Gross, mary.gross@fda.hhs.gov; or Georgiann Ienzi, Georgiann.Ienzi@fda.hhs.gov

Meeting Materials

Disclosure Forms


Back to Top